Back to top

EyePoint rises after enrollment update on Duravyu late-stage trials

EyePoint rises after enrollment update on Duravyu late-stage trials

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

EyePoint, Inc. (EYPT)